Veeva Systems

Always appreciate the chance to discuss how Commercial Evidence is helping to drive the industry forward and empowering teams to uncover more impactful insights to better serve HCPs and patients. Thank you Pharmaceutical Executive. We talked about how legacy call reports record that an HCP interaction happened. But they don't capture what happened in that interaction. While rigid dropdowns and picklists keep biopharma compliant, they leave the most valuable insights behind. Agentic AI changes that. Read more: https://lnkd.in/gW4drFn4 → Through the Agentic Call Report in Veeva Vault CRM, reps can use voice and free text to compliantly capture insights from HCP interactions, generating Commercial Evidence. 65% of these notes identify actionable treatment barriers, like prior authorization friction or local coverage issues. → Conversational AI on brand sites delivers compliant answers instantly to the customer, but also identifies exactly what physicians and patients are asking, highlighting content gaps and helping field reps know what is top-of-mind for HCPs. → Brand launch performance can be accelerated by more than 10% by turning narrative context into targeted action, the Commercial Evidence created from both field and digital interactions. When sales, marketing, and medical teams share this qualitative evidence, they can coordinate tactics swiftly to remove friction and bring necessary treatments to more patients. #VaultCRM #AI #Biopharma Ostro

Hearing about the latest innovations is why Daniel Jardanhazi-Kurutz from Bayer attends Veeva Commercial Summit, Europe. Commercial and medical life sciences leaders will come together in Copenhagen in November to explore the future of customer engagement in life sciences and discover innovations that will drive value. Join us to see how Agentic Commercial™ changes everything about the commercial model, from data to digital to field engagement to content operations. https://lnkd.in/gpDR3AmT #VeevaSummitEU

Right now, the industry can automate roughly half of all manual data queries. But unlocking this level of efficiency requires two things: 1) Adoption of risk-based data management (RBDM) with the provision of ICH E6(R3) 2) Shift towards a clinical data workbench to effectively implement risk-based approaches Confusion still exists around how to action a larger risk-based quality management (RBQM) strategy. Building on some of my previous posts, this third installment published in DIA outlines a clear path forward. It discusses the difference between RBQM and data-specific RBDM workflows and why a centralized clinical data hub is needed to scale automation. Read it here: https://lnkd.in/g3EjbfMG #RBDM #RBQM #GlobalForum

É com enorme satisfação que anunciamos a participação de grandes experts da indústria farmacêutica no Veeva Summit R&D + Quality Brasil 2026, confira: Track Clinical: Descubra os avanços na área com o case do Aché Laboratórios Farmacêuticos "Digitalização com Propósito: A Nova Era da Pesquisa Clínica", apresentado por Renata Herrera, Clinical Operational Manager. Track de Qualidade: Venha acompanhar o case da Pfizer "Integridade e Eficiência: A Jornada para uma Plataforma Única de Qualidade", apresentado por Claudia Lago, Gerente de Garantia da Qualidade. Para conferir mais detalhes da agenda e garantir a sua participação acesse:https://lnkd.in/dmVnu7xc #Veeva #VeevaSystems #VeevaSummit #VeevaRD #Qualidade #VeevaBrasil #VeevaLatAm

Com o apoio do Sindusfarma, a Veeva Systems realiza a 3ª edição do workshop “Estratégias e Melhores Práticas de Gestão de Riscos na Indústria Farmacêutica”, em Anápolis (GO). O encontro reúne profissionais das áreas de Qualidade, Controle de Qualidade (CQ), Regulatórios, P&D e TI para discutir desafios, estratégias e boas práticas para a gestão de riscos no setor. 📅 03 de setembro 📍 Hotel Intercity | Anápolis, GO Gratuito! Inscreva-se: https://lnkd.in/dUqWSKej #Sindusfarma #Veeva #IndustriaFarmaceutica #GestaoDeRiscos #Qualidade

UCB is taking a big step forward in how it gathers and acts on medical insights. Ivo Huybrechts, head medical insights, global medical affairs shares more in this video ⬇️ By switching to Veeva Medical Insights, teams now have instant visibility into all their insights allowing them to take strategic, data-driven actions, enabling: 💡Early detection of signals that will fuel launch strategy. 💡A clear view of emerging and historical trends 💡Deeper analysis of relevant topics Learn more here: https://lnkd.in/eTpXNc_x

“The patient experience is broken. It's broken because patient support is disconnected from access and reimbursement. Because we put too much focus on the services provided rather than the human that's waiting for the service.” Ryan Donk recently sat down with market access and patient services leaders at a growing, rare disease biotech to discuss the fix https://lnkd.in/e4qHR4am. Watch the full session to hear about their transformation and learn how biopharmas of all sizes use Veeva Vault Patient CRM to provide a better patient experience and compliantly improve cross team care coordination. #VaultCRM #PatientCRM #PatientServices

Clinical leaders are expressing low confidence in the accuracy of their data. According to a Harvard Business Review study, 97% of data used for business decisions is incomplete or inaccurate. Advantages of clean data, include: - Consistent, verified data at scale - Real-time, automated data maintenance - Operational efficiency and staff focus Learn more: https://lnkd.in/gyWCmgZy

The clinical trial "system of systems" is finally becoming one system. For years, running a trial meant stitching together disconnected tools — a CTMS to manage operations, an EDC to capture data, an eTMF for documents, and spreadsheets to bridge the gaps. Every handoff between them was an opportunity for delay, re-transcription, and error. The 2026 industry shift is clear: unified clinical trial platforms that break down these silos — connecting trial management, data capture, and oversight in one environment. At Indero, this isn't just theory. As an example, we adopted Veeva Vault as our Clinical Trial Management System (CTMS) and we've been connecting the EDC directly into it, so a data query raised during data capture can automatically trigger a protocol deviation in the CTMS. No manual re-keying between systems. One connected flow, from a single data point to the oversight action it demands. Why it matters? • Fewer manual handoffs so fewer errors • Real-time visibility for study teams • Faster, cleaner trials for the dermatology & rheumatology programs we run The platform is never the destination, better, faster science for patients is. But the right backbone is how we get there. How is your team unifying its clinical systems? #ClinicalTrials #CRO #ClinicalOperations #CTMS

For twenty years, eSource just moved the transcription problem to a different screen. At the Veeva Systems R&D and Quality Summit, I sat down with Manny Vazquez and Denali Rose to talk about why this generation of eSource is structurally different: the site owns it, operates it across their whole portfolio, and the data flows both ways. Enter a data point once and it goes wherever it needs to go, and when EDC raises a query, it comes back to the same window. The line that stuck with me: we keep trying to solve site problems by layering technology on top, and it just becomes a burden downstream. This time the fix starts with who owns the workflow. Thank you Jeremy Whittaker, Natasha G., and Deivis Mercado for making these conversations possible. Full interview with Manny and Denali on Clinical Trial Vanguard: https://lnkd.in/etEN2DpK